Chinenyenwa Sofia Anugwom
Family Medicine · San Joaquin
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Chinenyenwa Sofia Anugwom’s office at (559) 203-6640 to ask if they take your plan before you enroll.
California Medical Board record
Licence A165415 · Current
Licensed to practise in California · since 2019 · expires 2027-09-30 · Medical University of Lublin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$521,507 in 2024
Medicaid paid $521,507 for 7,832 billed services this clinician did in 2024, up to 219 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,720 | $471,841 |
| Short return visit (20+ min) | 2,705 | $25,778 |
| Return visit (30+ min) | 1,265 | $18,432 |
| Short return visit | 203 | $1,714 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 558 | $1,109 |
| Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use | 12 | $838 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 27 | $623 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B | 12 | $596 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 31 | $350 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 33 | $112 |
| HEMOGLOBIN | 91 | $59 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 41 | $28 |
| 2024 | 7,832 | 15 | 219 | $521,507 |
| 2023 | 8,757 | 17 | 230 | $592,307 |
| 2022 | 7,968 | 15 | 221 | $630,548 |
| 2021 | 4,133 | 8 | 151 | $405,094 |
| 2020 | 626 | 4 | 77 | $56,557 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,339 | $537,787 |
| Short return visit (20+ min) | 3,027 | $32,146 |
| Return visit (30+ min) | 990 | $16,992 |
| Short return visit | 223 | $1,814 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 90 | $1,358 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 472 | $996 |
| Prenatal care, at-risk enhanced service; education | 34 | $320 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 95 | $261 |
| Screening test, pure tone, air only | 32 | $125 |
| HEMOGLOBIN | 134 | $120 |
| Health behavior assessment | 14 | $112 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 85 | $93 |
2022
| Clinic visit/encounter, all-inclusive | 3,080 | $591,846 |
| Short return visit (20+ min) | 2,634 | $23,811 |
| Return visit (30+ min) | 865 | $9,238 |
| Short return visit | 219 | $1,718 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 156 | $1,598 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B | 25 | $801 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 429 | $541 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 83 | $300 |
| Health behavior assessment | 15 | $155 |
| Screening test, pure tone, air only | 17 | $148 |
| Bilateral quantitative screening test of visual acuity | 78 | $138 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 145 | $129 |
2021
| Clinic visit/encounter, all-inclusive | 2,179 | $403,927 |
| Short return visit (20+ min) | 1,143 | $686 |
| Return visit (30+ min) | 637 | $474 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 103 | $4 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 18 | $2 |
| HEMOGLOBIN | 24 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 15 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 348 | $56,194 |
| Return visit (30+ min) | 93 | $222 |
| Short return visit (20+ min) | 147 | $142 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 38 | $0 |
Drugs they prescribed that Part D paid
$263,123
Pharmacies billed $263,123 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
967 generic and 287 brand-name prescriptions · $263,123 in drug cost · 20 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 84 | $81,976 | $976 |
| Mounjaro | 61 | $64,802 | $1,062 |
| Ozempic | 29 | $29,880 | $1,030 |
| Basaglar Kwikpen U-100 | 21 | $8,348 | $398 |
| Atorvastatin | 146 | $2,311 | $16 |
See all 21 drugs
| Jardiance | 84 | $81,976 | $976 |
| Mounjaro | 61 | $64,802 | $1,062 |
| Ozempic | 29 | $29,880 | $1,030 |
| Basaglar Kwikpen U-100 | 21 | $8,348 | $398 |
| Atorvastatin | 146 | $2,311 | $16 |
| Levothyroxine | 28 | $1,502 | $54 |
| Metformin | 116 | $847 | $7 |
| Omeprazole | 40 | $696 | $17 |
| Lisinopril | 82 | $537 | $7 |
| Losartan | 41 | $515 | $13 |
| Rosuvastatin | 13 | $404 | $31 |
| Clopidogrel | 22 | $392 | $18 |
| Albuterol Sulfate Hfa | 13 | $382 | $29 |
| Amlodipine Besylate | 66 | $378 | $6 |
| Pioglitazone | 28 | $342 | $12 |
| Gabapentin | 30 | $310 | $10 |
| Hydralazine | 13 | $308 | $24 |
| Metoprolol | 34 | $235 | $7 |
| Ibuprofen | 25 | $190 | $8 |
| Hydrochlorothiazide | 27 | $113 | $4 |
| Lisinopril-Hydrochlorothiazide | 14 | $64 | $5 |
Year by year
| 2024 | 1,274 | 163 | None | 23% | $263,123 |
| 2023 | 1,145 | 164 | 1% (12) | 20% | $280,603 |
| 2022 | 1,244 | 175 | None | 18% | $202,538 |
| 2021 | 1,124 | 150 | None | 20% | $170,726 |
| 2020 | 104 | 50 | 0% (0) | 17% | $10,877 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Trulicity | 45 | $63,793 | $1,418 |
| Jardiance | 38 | $55,154 | $1,451 |
| Januvia | 15 | $13,431 | $895 |
| Basaglar Kwikpen U-100 | 40 | $12,775 | $319 |
| Lantus Solostar | 15 | $9,040 | $603 |
| Atorvastatin | 119 | $3,908 | $33 |
| Metformin | 78 | $2,042 | $26 |
| Amlodipine Besylate | 57 | $1,411 | $25 |
| Pioglitazone | 16 | $1,370 | $86 |
| Lisinopril | 61 | $1,369 | $22 |
| Losartan | 53 | $1,282 | $24 |
| Clopidogrel | 19 | $853 | $45 |
| Levothyroxine | 27 | $836 | $31 |
| Omeprazole | 30 | $748 | $25 |
| Gabapentin | 21 | $718 | $34 |
| Metoprolol | 22 | $628 | $29 |
| Hydralazine | 12 | $561 | $47 |
| Escitalopram | 18 | $483 | $27 |
| Diclofenac | 12 | $403 | $34 |
| Carvedilol | 19 | $243 | $13 |
| Hydrochlorothiazide | 40 | $228 | $6 |
| Metoprolol | 11 | $227 | $21 |
| Hydrocodone-Acetaminophen | 12 | $221 | $18 |
| Ibuprofen | 17 | $133 | $8 |
| Sertraline | 12 | $120 | $10 |
| Furosemide | 14 | $41 | $3 |
2022: 29 drugs
| Trulicity | 31 | $54,822 | $1,768 |
| Januvia | 25 | $33,916 | $1,357 |
| Jardiance | 17 | $29,066 | $1,710 |
| Basaglar Kwikpen U-100 | 37 | $11,570 | $313 |
| Eliquis | 16 | $9,041 | $565 |
| Lantus Solostar | 15 | $6,043 | $403 |
| Atorvastatin | 118 | $1,657 | $14 |
| Albuterol Sulfate Hfa | 17 | $849 | $50 |
| Gabapentin | 36 | $813 | $23 |
| Levothyroxine | 35 | $791 | $23 |
| Metformin | 75 | $683 | $9 |
| Losartan | 48 | $620 | $13 |
| Pioglitazone | 26 | $594 | $23 |
| Lisinopril | 73 | $544 | $7 |
| Fluticasone Propionate | 35 | $460 | $13 |
| Amlodipine Besylate | 65 | $411 | $6 |
| Hydralazine | 27 | $409 | $15 |
| Omeprazole | 24 | $344 | $14 |
| Metoprolol | 36 | $300 | $8 |
| Escitalopram | 11 | $232 | $21 |
| Carvedilol | 23 | $225 | $10 |
| Diclofenac | 11 | $217 | $20 |
| Metoprolol | 12 | $191 | $16 |
| Clopidogrel | 20 | $189 | $9 |
| Hydrochlorothiazide | 42 | $160 | $4 |
| Cyclobenzaprine | 11 | $140 | $13 |
| Sertraline | 13 | $123 | $9 |
| Ibuprofen | 15 | $84 | $6 |
| Glipizide | 13 | $70 | $5 |
2021: 23 drugs
| Januvia | 30 | $40,303 | $1,343 |
| Trulicity | 17 | $31,240 | $1,838 |
| Jardiance | 19 | $22,268 | $1,172 |
| Lantus Solostar | 22 | $6,219 | $283 |
| Basaglar Kwikpen U-100 | 20 | $5,494 | $275 |
| Atorvastatin | 83 | $1,791 | $22 |
| Albuterol Sulfate Hfa | 21 | $1,036 | $49 |
| Levothyroxine | 38 | $782 | $21 |
| Omeprazole | 35 | $654 | $19 |
| Losartan | 44 | $598 | $14 |
| Lisinopril | 64 | $589 | $9 |
| Metformin | 66 | $560 | $8 |
| Tamsulosin | 15 | $522 | $35 |
| Gabapentin | 38 | $507 | $13 |
| Glimepiride | 17 | $336 | $20 |
| Metoprolol | 15 | $279 | $19 |
| Fluticasone Propionate | 17 | $251 | $15 |
| Amlodipine Besylate | 37 | $202 | $5 |
| Metoprolol | 20 | $181 | $9 |
| Hydrochlorothiazide | 35 | $114 | $3 |
| Nifedipine Er | 12 | $100 | $8 |
| Ibuprofen | 14 | $78 | $6 |
| Furosemide | 13 | $31 | $2 |
Money from drug and device companies
$712 in 2025
| 2025 | 10 | 36 | None | $712 |
| 2024 | 8 | 23 | None | $427 |
| 2023 | 8 | 14 | None | $348 |
| 2022 | 10 | 17 | None | $599 |
| 2021 | 4 | 5 | None | $86 |
| 2020 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $237 | 6 payments
|
| Dynavax Technologies | Heplisav-B | $99 | 4 payments
|
| Lilly USA | Mounjaro | $93 | 6 payments
|
| Pfizer | Nurtec Odt | $72 | 4 payments
|
| Novo Nordisk | Ozempic | $62 | 3 payments
|
| Astellas Pharma US | Veozah | $43 | 2 payments
|
See all 31 published payments
| Astellas Pharma US | Meals · 2025-12-04 | Veozah | $24 |
| Cranial Technologies | Meals · 2025-11-20 | Doc Band | $19 |
| Novo Nordisk | Meals · 2025-11-04 | Ozempic | $22 |
| Cranial Technologies | Meals · 2025-11-04 | Doc Band | $6 |
| Abbvie | Meals · 2025-10-28 | Qulipta | $25 |
| Lilly USA | Meals · 2025-10-24 | Mounjaro | $17 |
| Pfizer | Meals · 2025-10-23 | Nurtec Odt | $24 |
| Exact Sciences | Meals · 2025-10-21 | The Cologuard Plus Collection Kit | $23 |
| Pfizer | Meals · 2025-08-21 | Nurtec Odt | $19 |
| Lilly USA | Meals · 2025-08-20 | Mounjaro | $15 |
| Lilly USA | Meals · 2025-07-16 | Mounjaro | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-10 | Breztri | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-10 | None | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-02 | Breztri | $27 |
| Lilly USA | Meals · 2025-06-26 | Mounjaro | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-04 | Airsupra | $117 |
| Shield Therapeutics | Meals · 2025-05-20 | Accrufer | $16 |
| Novo Nordisk | Meals · 2025-04-24 | Ozempic | $13 |
| Novo Nordisk | Meals · 2025-04-23 | Wegovy | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-22 | Breztri | $24 |
| Lilly USA | Meals · 2025-04-21 | Mounjaro | $14 |
| Dynavax Technologies | Meals · 2025-04-16 | Heplisav-B | $23 |
| Dynavax Technologies | Meals · 2025-04-15 | Heplisav-B | $20 |
| Pfizer | Meals · 2025-03-27 | Prevnar 20 | $15 |
| Astellas Pharma US | Meals · 2025-03-24 | Veozah | $19 |
| Lilly USA | Meals · 2025-03-13 | Mounjaro | $14 |
| Shield Therapeutics | Meals · 2025-03-06 | Accrufer | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-19 | Breztri | $18 |
| Dynavax Technologies | Meals · 2025-02-06 | Heplisav-B | $26 |
| Pfizer | Meals · 2025-01-27 | Nurtec Odt | $15 |
| Dynavax Technologies | Meals · 2025-01-23 | Heplisav-B | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $427
| Exact Sciences | Cologuard Collection Kit | $106 | 5 payments
|
| Lilly USA | Mounjaro | $95 | 6 payments
|
| Pfizer | Paxlovid | $63 | 3 payments
|
| Phathom Pharmaceuticals | Voquezna | $45 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $42 | 2 payments
|
| Mayne Pharma Commercial | None | $29 | 2 payments
|
| GlaxoSmithKline | Bexsero | $29 | 2 payments
|
| Astellas Pharma US | Veozah | $18 | 1 payment
|
2023: $348
| AstraZeneca Pharmaceuticals LP | Farxiga | $141 | 3 payments
|
| Lilly USA | Mounjaro | $56 | 3 payments
|
| Pfizer | Prevnar 13 | $53 | 3 payments
|
| Sanofi Pasteur | Menquadfi | $21 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $20 | 1 payment
|
| Merck Sharp & Dohme | Proquad | $20 | 1 payment
|
| GlaxoSmithKline | Bexsero | $19 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $18 | 1 payment
|
2022: $599
| Lilly USA | Mounjaro | $166 | 5 payments
|
| Novo Nordisk | Ozempic | $133 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $112 | 1 payment
|
| Abbvie | Mavyret | $53 | 2 payments
|
| VBI Vaccines (Delaware) | Prehevbrio | $33 | 2 payments
|
| GlaxoSmithKline | Bexsero | $24 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $22 | 1 payment
|
| Cranial Technologies | Doc Band | $20 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $19 | 1 payment
|
| Organon | Nexplanon | $17 | 1 payment
|
2021: $86
| Novo Nordisk | Rybelsus | $35 | 2 payments
|
| Lilly USA | Basaglar | $19 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
2020: $12
| Novo Nordisk | Ozempic | $12 | 1 payment
|
Professional record
- NPI
- 1619406063
- Licence
- CA A165415California A165415: Current · expires 2027-09-30
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 737, San Joaquin, CA, 93660
- NPI first listed
- 2017-06-08
- NPI last updated
- 2022-07-21
- NPI record certified
- 2021-02-10
This is when the NPI record was last certified, not a medical board exam.